1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Why are they in trouble ?

Discussion in 'Physicians Choice Laboratory Services' started by anonymous, Jan 29, 2016 at 4:18 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    what happened to them ? Why are they in trouble ?
     

  2. anonymous

    anonymous Guest

    not sure outside incompetent ownership, management with their own self serving agendas, no commercial contracts, me too product, operations that is untouchable and immature, reps that send specimens to other labs to get paid more, nepotism,
    other then that we really can't put our finger on it.
     
  3. anonymous

    anonymous Guest

    Thrown in the 1x medicare idea, thanks AC and PS, and you have a disaster. AC sure talks a good game, but its all hot air.
     
  4. anonymous

    anonymous Guest

    When you treat your doctors, their staff, their patients, and your own employees like they are actually doing YOU a favor by "giving" you samples,
    This is what you get!
    Next time, don't think you and your egos are bigger than the whole. You ran the company into the ground and there's a lesson there. Hope you learn from it.